Plain-English translation of NCT07349875 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether a medication called colchicine, taken as a daily pill, can help protect your heart when added to your regular heart disease medications. Researchers believe that reducing inflammation in your blood vessels may prevent future heart attacks, strokes, and the need for heart procedures. The trial will follow about 3,800 people with stable heart disease for up to three years.
Many people with heart disease continue to have heart attacks and strokes even when taking standard medications. This trial is testing whether this medication, which reduces inflammation in blood vessels, could prevent these serious events in people whose heart disease is stable but who have plaque buildup in their arteries.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either take your regular heart medications alone, or to take those same medications plus one colchicine tablet (0.5 mg) once daily. You will attend clinic visits to have your health monitored, including blood tests to check for any side effects. The study will track whether you experience any heart attacks, strokes, or other heart-related events over the following 1–3 years.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China